Press Releases

Press Releases

    Date Title View
    12/22/20
    Summary ToggleHorizon Therapeutics plc to Present at the 39th Annual J.P. Morgan Healthcare Conference
    PDF Version
    12/17/20
    Summary ToggleHorizon Therapeutics plc Announces Short-Term TEPEZZA® (teprotumumab-trbw) Supply Disruption Due to Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production
    PDF Version
    12/03/20
    Summary ToggleHorizon Therapeutics plc Provides $1 Million in Scholarships to Help Economically Disadvantaged Students and Students of Color Further Their Liberal Arts and Health Professions Education
    PDF Version
    12/02/20
    Summary ToggleGreat Place to Work Names Horizon Therapeutics plc to Best Workplaces for Parents List
    PDF Version
    11/30/20
    Summary ToggleHorizon Therapeutics plc Donates Additional $1.2 Million to Support COVID-19 Relief Efforts in Illinois and Other Impacted U.S. and International Communities
    PDF Version
    11/25/20
    Summary ToggleHorizon Therapeutics plc to Participate in Upcoming Investor Conferences
    PDF Version
    11/23/20
    Summary ToggleHorizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
    PDF Version
    11/17/20
    Summary ToggleNational Association for Business Resources Names Horizon Therapeutics One of the Best and Brightest Companies to Work For in the Nation
    PDF Version
    11/16/20
    Summary ToggleFirst Thyroid Eye Disease (TED) Awareness Week to Increase Education and Understanding of Vision-Threatening Disease
    PDF Version
    11/13/20
    Summary ToggleNew Data Build on Growing Evidence Supporting TEPEZZA® (teprotumumab-trbw) Efficacy in Thyroid Eye Disease (TED), Including in Patients With Less Severe Disease and Longer Disease Duration
    PDF Version
    Displaying 1 - 10 of 72 results